Home Newsfeeds Raymond James Downgrades ON Semiconductor to Market Perform

Raymond James Downgrades ON Semiconductor to Market Perform

Raymond James analyst Melissa Fairbanks downgrades ON Semiconductor (NASDAQ:ON) from Outperform to Market Perform.

byBenzinga Newsdesk

March 2, 2023

1 minute read

Raymond James analyst Melissa Fairbanks downgrades ON Semiconductor (NASDAQ:ON) from Outperform to Market Perform.

Why ABVC Biopharma Stock Is Trading Higher

By Henry Khederian

July 25, 10:50 AM

ABVC Biopharma Inc (NASDAQ: ABVC) shares are trading higher by 3.21% to $4.03 Tuesday morning after the company announced a 1-for-10 reverse stock split.

ABVC

Salarius Pharmaceuticals Reports No Adverse Safety Signals from Two Good Laboratory Practice Toxicology Studies With Its Targeted Protein Degrader SP-3164

By Benzinga Newsdesk

May 1, 8:34 AM

Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies for patients in need of new treatment options,

SLRX

Glow Preparing To Launch Multiple In-House Cannabis Consumer Brands

By Vuk Zdinjak

July 28, 8:48 AM

Glow LifeTech Corp. (OTCPK:GLWLF) (CSE:GLOW) (FSE:9DO) announced the upcoming launch of multiple in-house cannabis consumer brands powered by its portfolio of proprietary ingredient technologies. The company expects to commercially deploy its products into the Canadian cannabis market as early as Q3 2023.

CSE:GLOW

Raymond James Maintains Outperform on Procter & Gamble, Raises Price Target to $165

By Benzinga Newsdesk

November 21, 6:10 AM

Raymond James analyst Olivia Tong maintains Procter & Gamble (NYSE:PG) with a Outperform and raises the price target from $155 to $165.

Raymond James Downgrades ON Semiconductor to Market Perform

Related Posts

Why ABVC Biopharma Stock Is Trading Higher

Salarius Pharmaceuticals Reports No Adverse Safety Signals from Two Good Laboratory Practice Toxicology Studies With Its Targeted Protein Degrader SP-3164

Glow Preparing To Launch Multiple In-House Cannabis Consumer Brands

Raymond James Maintains Outperform on Procter & Gamble, Raises Price Target to $165